SULFUR HEXAFLUORIDE

SULFUR HEXAFLUORIDE was reported 0 times

SULFUR HEXAFLUORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRIEF PSYCHOTIC DISORDER WITHOUT MARKED STRESSORS 1 0.2500
1 CHOROIDAL HAEMATOMA 1 0.0909
2 WEAN FROM VENTILATOR 1 0.0769
3 AGONAL RESPIRATION 12 0.0424
4 FEMORAL PULSE DECREASED 1 0.0323
5 CONTRAST MEDIA REACTION 69 0.0292
6 NON-OBSTRUCTIVE CARDIOMYOPATHY 1 0.0278
7 PRODUCT RECONSTITUTION QUALITY ISSUE 24 0.0268
8 CAROTID PULSE DECREASED 1 0.0222
9 MACULAR SCAR 4 0.0206
10 OXYGEN SATURATION IMMEASURABLE 2 0.0182
11 LUNG ASSIST DEVICE THERAPY 1 0.0161
12 POLYMERS ALLERGY 1 0.0145
13 MALFORMATION VENOUS 1 0.0143
14 BLOOD PRESSURE IMMEASURABLE 20 0.0130
15 PULSELESS ELECTRICAL ACTIVITY 50 0.0120
16 CORNEAL BLEEDING 1 0.0104
17 CONTRAST MEDIA ALLERGY 19 0.0104
18 AGONAL RHYTHM 1 0.0103
19 RETINOPATHY PROLIFERATIVE 2 0.0103
20 PULSE ABSENT 48 0.0101
21 LICE INFESTATION 2 0.0095
22 WALL MOTION SCORE INDEX ABNORMAL 1 0.0091
23 DECORTICATE POSTURE 1 0.0089
24 RETINAL PIGMENT EPITHELIAL TEAR 6 0.0086
25 PRODUCT STERILITY ISSUE 1 0.0081
26 ECHOCARDIOGRAM 1 0.0079
27 HYPHAEMA 4 0.0077
28 BRIEF RESOLVED UNEXPLAINED EVENT 1 0.0076
29 OPTIC NERVE COMPRESSION 1 0.0073
30 HYPOTONY OF EYE 3 0.0071
31 MECHANICAL VENTILATION COMPLICATION 1 0.0067
32 BLADDER SPHINCTER ATONY 1 0.0065
33 ALLERGY TEST NEGATIVE 1 0.0064
34 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 20 0.0060
35 ACUTE CARDIAC EVENT 1 0.0058
36 REACTION TO AZO-DYES 1 0.0058
37 PROCEDURAL FAILURE 1 0.0056
38 CHOROIDAL DETACHMENT 3 0.0054
39 NIPPLE EXUDATE BLOODY 1 0.0053
40 KOUNIS SYNDROME 12 0.0053
41 MACULAR HOLE 7 0.0052
42 CHOROIDAL HAEMORRHAGE 1 0.0052
43 CARDIAC PROCEDURE COMPLICATION 3 0.0049
44 ORAL DYSAESTHESIA 1 0.0049
45 RESUSCITATION 8 0.0048
46 ANEMBRYONIC GESTATION 1 0.0048
47 RHEGMATOGENOUS RETINAL DETACHMENT 1 0.0048
48 LENS DISLOCATION 1 0.0048
49 UNRESPONSIVE TO STIMULI 123 0.0048
50 ANAPHYLACTIC REACTION 252 0.0046
51 PRODUCT INTOLERANCE 1 0.0045
52 ALLERGY TEST POSITIVE 2 0.0044
53 NECROTISING SOFT TISSUE INFECTION 1 0.0043
54 AIR EMBOLISM 2 0.0042
55 MEAN ARTERIAL PRESSURE DECREASED 1 0.0040
56 CYANOSIS CENTRAL 1 0.0038
57 DRUG EFFECT PROLONGED 2 0.0036
58 CHOROIDAL NEOVASCULARISATION 3 0.0035
59 VITREOUS HAEMORRHAGE 9 0.0033
60 VASCULAR COMPRESSION 1 0.0032
61 CYANOSIS 49 0.0031
62 BLOOD VISCOSITY DECREASED 1 0.0030
63 PSEUDOSTROKE 1 0.0029
64 XANTHOPSIA 1 0.0027
65 RETINAL VASCULAR OCCLUSION 2 0.0027
66 ANAPHYLACTOID REACTION 11 0.0027
67 CAPILLARY DISORDER 1 0.0026
68 FEELING HOT 157 0.0026
69 WALKING DISTANCE TEST ABNORMAL 1 0.0026
70 HYPORESPONSIVE TO STIMULI 3 0.0026
71 INCISION SITE PAIN 3 0.0026
72 PRODUCT LABEL ON WRONG PRODUCT 1 0.0025
73 PHARYNGEAL PARAESTHESIA 4 0.0025
74 ANAPHYLACTIC SHOCK 64 0.0025
75 FOAMING AT MOUTH 5 0.0025
76 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 2 0.0025
77 USE OF ACCESSORY RESPIRATORY MUSCLES 1 0.0024
78 VASCULAR STENT STENOSIS 1 0.0024
79 VITAL FUNCTIONS ABNORMAL 2 0.0023
80 ANAL SPHINCTER ATONY 1 0.0023
81 SLOW RESPONSE TO STIMULI 3 0.0023
82 ABDOMINAL SEPSIS 2 0.0023
83 THERAPEUTIC PRODUCT EFFECT PROLONGED 1 0.0022
84 PRESYNCOPE 53 0.0022
85 SKIN TEST POSITIVE 2 0.0021
86 ADRENAL NEOPLASM 1 0.0021
87 PALLOR 57 0.0021
88 RED BLOOD CELLS URINE POSITIVE 2 0.0021
89 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
90 FLUSHING 196 0.0019
91 EYE MOVEMENT DISORDER 13 0.0019
92 BLOOD PRESSURE DECREASED 125 0.0019
93 BLOOD MAGNESIUM ABNORMAL 1 0.0018
94 CARDIOSPASM 1 0.0018
95 HYPERHIDROSIS 231 0.0018
96 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
97 APNOEIC ATTACK 1 0.0018
98 CARDIO-RESPIRATORY ARREST 74 0.0018
99 RETINAL VASCULAR DISORDER 1 0.0017
100 GRAFT COMPLICATION 1 0.0017
101 IRREGULAR BREATHING 1 0.0017
102 OXYGEN SATURATION DECREASED 94 0.0017
103 GRUNTING 1 0.0017
104 VENTRICULAR FIBRILLATION 18 0.0016
105 GASTRIC ULCER PERFORATION 2 0.0016
106 LARYNGEAL DISCOMFORT 1 0.0016
107 SUSPECTED OFF LABEL USE 7 0.0015
108 ENTEROCOCCUS TEST POSITIVE 1 0.0015
109 KLEBSIELLA TEST POSITIVE 1 0.0015
110 TYPE I HYPERSENSITIVITY 5 0.0014
111 GLASSY EYES 1 0.0014
112 BORDERLINE PERSONALITY DISORDER 1 0.0014
113 CARDIAC ARREST 116 0.0014
114 TRYPTASE INCREASED 1 0.0014
115 BRONCHIAL WALL THICKENING 1 0.0014
116 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
117 HEMIANOPIA HOMONYMOUS 1 0.0014
118 AORTIC VALVE SCLEROSIS 1 0.0014
119 HEART SOUNDS ABNORMAL 1 0.0013
120 AGE-RELATED MACULAR DEGENERATION 2 0.0013
121 HEART RATE DECREASED 46 0.0013
122 ELECTROCARDIOGRAM PR PROLONGATION 1 0.0013
123 MYOPERICARDITIS 1 0.0013
124 RETCHING 27 0.0013
125 EYELID FUNCTION DISORDER 1 0.0013
126 URETERIC STENOSIS 1 0.0012
127 PARAESTHESIA ORAL 18 0.0012
128 ARTERIOSPASM CORONARY 5 0.0012
129 INJECTION RELATED REACTION 2 0.0012
130 DYSCHROMATOPSIA 1 0.0012
131 NON-INFECTIOUS ENDOPHTHALMITIS 1 0.0012
132 TONGUE PRURITUS 1 0.0012
133 RESPIRATORY DISTRESS 32 0.0012
134 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
135 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
136 HYPERLEUKOCYTOSIS 1 0.0011
137 UPPER AIRWAY OBSTRUCTION 1 0.0011
138 PHARYNGEAL SWELLING 11 0.0011
139 VASOSPASM 1 0.0011
140 COLD SWEAT 19 0.0011
141 BRADYCARDIA 57 0.0011
142 FOREIGN BODY IN EYE 1 0.0010
143 VOMITING PROJECTILE 3 0.0010
144 HYPERVIGILANCE 1 0.0010
145 VENTRICULAR TACHYCARDIA 17 0.0010
146 CROSS SENSITIVITY REACTION 1 0.0010
147 SUBCUTANEOUS EMPHYSEMA 1 0.0010
148 RESPIRATORY RATE INCREASED 9 0.0010
149 HEMIANOPIA 1 0.0010
150 CONJUNCTIVAL OEDEMA 1 0.0010
151 THROAT TIGHTNESS 26 0.0010
152 CONSCIOUSNESS FLUCTUATING 1 0.0010
153 TACHYPNOEA 13 0.0010
154 URETEROLITHIASIS 1 0.0010
155 EXOPHTHALMOS 2 0.0009
156 KIDNEY ENLARGEMENT 1 0.0009
157 CLAUSTROPHOBIA 1 0.0009
158 PILOERECTION 1 0.0009
159 IMMEDIATE POST-INJECTION REACTION 1 0.0009
160 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
161 PERIRECTAL ABSCESS 1 0.0009
162 AORTIC DILATATION 1 0.0009
163 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
164 MYOCARDIAL INJURY 1 0.0009
165 DISTRIBUTIVE SHOCK 2 0.0009
166 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
167 ADMINISTRATION SITE PAIN 1 0.0009
168 DEFAECATION URGENCY 6 0.0009
169 RECTAL ULCER 1 0.0009
170 RETINAL HAEMORRHAGE 6 0.0008
171 HYPOTENSION 168 0.0008
172 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
173 EMBOLISM ARTERIAL 1 0.0008
174 PANIC REACTION 6 0.0008
175 HYPOXIA 29 0.0008
176 CEREBRAL ARTERY EMBOLISM 1 0.0008
177 URINARY INCONTINENCE 24 0.0008
178 RESPIRATORY ARREST 22 0.0008
179 PRODUCT COLOUR ISSUE 4 0.0008
180 DACRYOSTENOSIS ACQUIRED 1 0.0008
181 CARDIOGENIC SHOCK 11 0.0008
182 RETINAL DETACHMENT 7 0.0008
183 PARAESTHESIA 119 0.0008
184 HEART RATE INCREASED 74 0.0007
185 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
186 HYPERSENSITIVITY 136 0.0007
187 HYPOAESTHESIA ORAL 11 0.0007
188 ENDOTRACHEAL INTUBATION 2 0.0007
189 SENSATION OF FOREIGN BODY 6 0.0007
190 CULTURE URINE POSITIVE 1 0.0007
191 SINUS TACHYCARDIA 10 0.0007
192 INTENSIVE CARE 1 0.0007
193 INJECTION SITE HYPOAESTHESIA 1 0.0007
194 LOSS OF CONSCIOUSNESS 89 0.0007
195 RENAL INFARCT 1 0.0007
196 TACHYCARDIA 61 0.0007
197 GENERALISED ANXIETY DISORDER 1 0.0007
198 EMBOLISM VENOUS 2 0.0007
199 MYOCLONIC EPILEPSY 1 0.0007
200 ERYTHEMA 135 0.0007
201 ISCHAEMIA 3 0.0007
202 PROCEDURAL COMPLICATION 5 0.0007
203 ATRIOVENTRICULAR BLOCK 5 0.0006
204 COAGULATION TIME PROLONGED 1 0.0006
205 SEIZURE 74 0.0006
206 SINUS ARREST 1 0.0006
207 INCOHERENT 4 0.0006
208 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
209 OEDEMA MOUTH 2 0.0006
210 ACUTE MYOCARDIAL INFARCTION 18 0.0006
211 ACUTE CORONARY SYNDROME 5 0.0006
212 TROPONIN I INCREASED 1 0.0006
213 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
214 DYSPNOEA 335 0.0006
215 SEIZURE LIKE PHENOMENA 1 0.0006
216 CHEST PAIN 108 0.0006
217 VENTRICULAR EXTRASYSTOLES 6 0.0006
218 PUPIL FIXED 1 0.0006
219 HYPOPNOEA 2 0.0006
220 ANAL INCONTINENCE 5 0.0006
221 SINUS NODE DYSFUNCTION 1 0.0005
222 AURA 1 0.0005
223 TUNNEL VISION 1 0.0005
224 BURNING SENSATION 37 0.0005
225 SINUS BRADYCARDIA 5 0.0005
226 OCULAR HYPERTENSION 1 0.0005
227 TORSADE DE POINTES 4 0.0005
228 RESPIRATORY ACIDOSIS 2 0.0005
229 VASCULAR STENT THROMBOSIS 1 0.0005
230 THROAT IRRITATION 22 0.0005
231 BREAST DISORDER 1 0.0005
232 LARYNGEAL OEDEMA 3 0.0005
233 QUADRIPLEGIA 1 0.0005
234 TONGUE BITING 1 0.0005
235 PHOTOPSIA 3 0.0005
236 NEUROGENIC BLADDER 1 0.0005
237 OPTIC NEUROPATHY 1 0.0005
238 HYPERPYREXIA 2 0.0005
239 SKIN LACERATION 5 0.0005
240 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
241 HEAD DISCOMFORT 8 0.0005
242 BLOOD CREATINE INCREASED 2 0.0005
243 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
244 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
245 MICTURITION URGENCY 5 0.0004
246 ORAL PRURITUS 1 0.0004
247 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
248 CHEST DISCOMFORT 44 0.0004
249 SKIN ABRASION 2 0.0004
250 URINARY HESITATION 1 0.0004
251 PULSE ABNORMAL 1 0.0004
252 STARING 1 0.0004
253 SLOW SPEECH 1 0.0004
254 TRANSPLANT FAILURE 1 0.0004
255 BREATH SOUNDS ABNORMAL 2 0.0004
256 PROTEIN URINE PRESENT 2 0.0004
257 VASODILATATION 1 0.0004
258 DYSPHORIA 2 0.0004
259 INTRAOCULAR PRESSURE INCREASED 5 0.0004
260 FAILURE TO THRIVE 2 0.0004
261 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
262 INCONTINENCE 4 0.0004
263 BLOOD POTASSIUM ABNORMAL 1 0.0004
264 BREAST SWELLING 1 0.0004
265 WHEEZING 22 0.0004
266 SYNCOPE 37 0.0004
267 CLUMSINESS 1 0.0004
268 CHOKING SENSATION 2 0.0004
269 PLEURITIC PAIN 1 0.0004
270 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
271 ACUTE PULMONARY OEDEMA 2 0.0004
272 SWOLLEN TONGUE 11 0.0004
273 INJECTION SITE SCAR 1 0.0004
274 BRONCHOSPASM 5 0.0004
275 NAUSEA 277 0.0003
276 HYPERVENTILATION 2 0.0003
277 TASTE DISORDER 7 0.0003
278 STRESS CARDIOMYOPATHY 2 0.0003
279 OCULAR HYPERAEMIA 16 0.0003
280 BRAIN HERNIATION 1 0.0003
281 ATYPICAL PNEUMONIA 1 0.0003
282 ENDOPHTHALMITIS 2 0.0003
283 HYPERCAPNIA 1 0.0003
284 DIZZINESS 162 0.0003
285 MENTAL STATUS CHANGES 9 0.0003
286 PRURITUS 120 0.0003
287 SNEEZING 7 0.0003
288 POSTURE ABNORMAL 1 0.0003
289 NEPHRITIS 1 0.0003
290 BK VIRUS INFECTION 1 0.0003
291 CIRCULATORY COLLAPSE 5 0.0003
292 EAR DISCOMFORT 3 0.0003
293 MUSCULOSKELETAL DISCOMFORT 5 0.0003
294 RESPIRATION ABNORMAL 2 0.0003
295 EAR PRURITUS 1 0.0003
296 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
297 PRODUCT CONTAMINATION 1 0.0003
298 URTICARIA 47 0.0003
299 HOT FLUSH 21 0.0003
300 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
301 VENTRICULAR ARRHYTHMIA 1 0.0003
302 ALCOHOL USE 1 0.0003
303 HYPOPHOSPHATAEMIA 2 0.0003
304 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
305 THROAT CLEARING 1 0.0003
306 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
307 SNORING 1 0.0003
308 MYOCARDIAL ISCHAEMIA 3 0.0003
309 TROPONIN INCREASED 2 0.0003
310 BACK PAIN 61 0.0003
311 HAEMODYNAMIC INSTABILITY 2 0.0003
312 TONGUE OEDEMA 1 0.0003
313 COMMUNICATION DISORDER 1 0.0003
314 DEVICE RELATED INFECTION 4 0.0003
315 APNOEA 2 0.0003
316 CARDIOPULMONARY FAILURE 1 0.0003
317 VENOUS THROMBOSIS 1 0.0003
318 NO ADVERSE EVENT 46 0.0003
319 BLOOD ALBUMIN DECREASED 2 0.0003
320 FEELING COLD 7 0.0003
321 SENSORY DISTURBANCE 4 0.0002
322 DECUBITUS ULCER 2 0.0002
323 PRODUCT PREPARATION ERROR 5 0.0002
324 LETHARGY 14 0.0002
325 EXTRAVASATION 1 0.0002
326 FEELING ABNORMAL 58 0.0002
327 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
328 EMBOLISM 2 0.0002
329 DYSARTHRIA 9 0.0002
330 LIP OEDEMA 1 0.0002
331 BUNDLE BRANCH BLOCK LEFT 1 0.0002
332 TONGUE DISCOMFORT 1 0.0002
333 AORTIC VALVE INCOMPETENCE 1 0.0002
334 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
335 TENSION HEADACHE 1 0.0002
336 METASTATIC NEOPLASM 1 0.0002
337 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
338 VOMITING 108 0.0002
339 ORTHOSTATIC HYPOTENSION 4 0.0002
340 ADVERSE REACTION 3 0.0002
341 BLOOD PRESSURE INCREASED 34 0.0002
342 OROPHARYNGEAL DISCOMFORT 2 0.0002
343 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
344 COUGH 61 0.0002
345 SHOCK 5 0.0002
346 ORAL DISCOMFORT 3 0.0002
347 FLANK PAIN 2 0.0002
348 ACUTE RESPIRATORY FAILURE 4 0.0002
349 HYPERCHOLESTEROLAEMIA 2 0.0002
350 DIZZINESS POSTURAL 2 0.0002
351 HAEMORRHAGE INTRACRANIAL 3 0.0002
352 SALIVARY HYPERSECRETION 2 0.0002
353 SWELLING FACE 13 0.0002
354 CORONARY ARTERY STENOSIS 1 0.0002
355 DRY THROAT 2 0.0002
356 NEUTROPHIL COUNT INCREASED 2 0.0002
357 TRISMUS 1 0.0002
358 PANIC ATTACK 7 0.0002
359 TONSILLITIS 1 0.0002
360 RESTLESSNESS 7 0.0002
361 AGITATION 14 0.0002
362 SCRATCH 2 0.0002
363 ASPIRATION 2 0.0002
364 HYPOAESTHESIA 27 0.0002
365 LIP SWELLING 6 0.0002
366 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
367 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
368 FACE OEDEMA 3 0.0002
369 PERIORBITAL SWELLING 1 0.0002
370 MITRAL VALVE INCOMPETENCE 2 0.0002
371 ABDOMINAL PAIN 41 0.0002
372 BLOOD URIC ACID INCREASED 1 0.0002
373 SKIN WARM 1 0.0002
374 LYMPHOCYTE COUNT DECREASED 3 0.0002
375 PULMONARY EMBOLISM 16 0.0002
376 THIRST 3 0.0002
377 INFUSION RELATED REACTION 11 0.0002
378 ATRIAL FIBRILLATION 16 0.0002
379 RESPIRATORY DEPRESSION 2 0.0002
380 TREMOR 27 0.0002
381 MALAISE 71 0.0002
382 INFUSION SITE EXTRAVASATION 1 0.0002
383 PRE-EXISTING CONDITION IMPROVED 1 0.0002
384 PNEUMONIA ASPIRATION 4 0.0002
385 SWELLING OF EYELID 1 0.0002
386 ABDOMINAL PAIN LOWER 4 0.0002
387 PRODUCT PREPARATION ISSUE 1 0.0002
388 SKIN DISCOLOURATION 7 0.0002
389 PRODUCT FORMULATION ISSUE 1 0.0002
390 DISORIENTATION 6 0.0002
391 PRODUCT PHYSICAL ISSUE 3 0.0001
392 POSTOPERATIVE WOUND INFECTION 1 0.0001
393 DYSKINESIA 6 0.0001
394 PERIPHERAL COLDNESS 2 0.0001
395 DROOLING 1 0.0001
396 EXTRASYSTOLES 1 0.0001
397 RASH MACULAR 5 0.0001
398 ORAL DISORDER 1 0.0001
399 MOUTH HAEMORRHAGE 1 0.0001
400 ANGIOEDEMA 6 0.0001
401 BLINDNESS TRANSIENT 1 0.0001
402 SPEECH DISORDER 7 0.0001
403 HYDRONEPHROSIS 1 0.0001
404 TINNITUS 6 0.0001
405 BOWEL MOVEMENT IRREGULARITY 1 0.0001
406 MUSCULOSKELETAL CHEST PAIN 2 0.0001
407 EJECTION FRACTION DECREASED 2 0.0001
408 HEADACHE 80 0.0001
409 TRICUSPID VALVE INCOMPETENCE 1 0.0001
410 MYASTHENIA GRAVIS 1 0.0001
411 SUBSTANCE ABUSE 1 0.0001
412 ASPHYXIA 1 0.0001
413 ENCEPHALOPATHY 3 0.0001
414 ABNORMAL FAECES 1 0.0001
415 DYSGEUSIA 9 0.0001
416 HEMIPLEGIA 1 0.0001
417 BLOOD UREA INCREASED 2 0.0001
418 EYE PRURITUS 4 0.0001
419 FACIAL PARALYSIS 1 0.0001
420 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
421 CARDIAC MURMUR 1 0.0001
422 PYELONEPHRITIS 1 0.0001
423 VERTIGO 7 0.0001
424 DISCOMFORT 7 0.0001
425 URINE OUTPUT DECREASED 1 0.0001
426 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
427 ISCHAEMIC STROKE 2 0.0001
428 FACIAL PAIN 1 0.0001
429 PULMONARY OEDEMA 5 0.0001
430 MYOSITIS 1 0.0001
431 RESPIRATORY FAILURE 8 0.0001
432 UROSEPSIS 1 0.0001
433 CONJUNCTIVITIS 2 0.0001
434 NECK PAIN 6 0.0001
435 HYPOCALCAEMIA 2 0.0001
436 ANXIETY 30 0.0001
437 FEELING JITTERY 2 0.0001
438 EYE INFLAMMATION 1 0.0001
439 RASH ERYTHEMATOUS 5 0.0001
440 PULMONARY FIBROSIS 2 0.0001
441 ATELECTASIS 1 0.0001
442 ERUCTATION 2 0.0001
443 VITAMIN D DEFICIENCY 1 0.0001
444 PALPITATIONS 12 0.0001
445 HOSPICE CARE 1 0.0001
446 HYPOTONIA 1 0.0001
447 BRAIN INJURY 1 0.0001
448 APHASIA 3 0.0001
449 HYPOTHERMIA 1 0.0001
450 INJURY ASSOCIATED WITH DEVICE 2 0.0001
451 SLUGGISHNESS 1 0.0001
452 ADVERSE EVENT 9 0.0001
453 FEMUR FRACTURE 3 0.0001
454 PETECHIAE 1 0.0001
455 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
456 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
457 CHILLS 11 0.0001
458 BREAST PAIN 1 0.0001
459 HYPERTENSIVE CRISIS 1 0.0001
460 OCULAR DISCOMFORT 1 0.0001
461 FISTULA 1 0.0001
462 MYOCARDITIS 1 0.0001
463 MUSCLE TWITCHING 2 0.0001
464 ELECTROLYTE IMBALANCE 1 0.0001
465 EYELID OEDEMA 1 0.0001
466 BACTERAEMIA 1 0.0001
467 MUSCLE RIGIDITY 1 0.0001
468 CEREBRAL INFARCTION 2 0.0001
469 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
470 INJECTION SITE EXTRAVASATION 1 0.0001
471 GENERALISED OEDEMA 1 0.0001
472 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
473 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
474 CARDIOVASCULAR DISORDER 2 0.0001
475 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
476 MYDRIASIS 1 0.0001
477 GENITAL HAEMORRHAGE 1 0.0001
478 ABDOMINAL PAIN UPPER 16 0.0001
479 INJECTION SITE INDURATION 1 0.0001
480 FEBRILE NEUTROPENIA 5 0.0001
481 MALIGNANT MELANOMA 1 0.0001
482 PAIN OF SKIN 2 0.0001
483 DRUG EFFECT DECREASED 4 0.0001
484 CONFUSIONAL STATE 12 0.0001
485 SINUS CONGESTION 1 0.0001
486 PNEUMONITIS 2 0.0001
487 RHABDOMYOLYSIS 3 0.0001
488 ACUTE KIDNEY INJURY 11 0.0001
489 HAEMOPTYSIS 2 0.0001
490 BLOOD TEST ABNORMAL 1 0.0001
491 RASH 31 0.0001
492 PAIN IN JAW 2 0.0001
493 DIALYSIS 1 0.0001
494 SEPTIC SHOCK 3 0.0001
495 PRODUCT QUALITY ISSUE 9 0.0001
496 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
497 OSTEOPENIA 1 0.0001
498 VISION BLURRED 9 0.0001
499 ANKLE FRACTURE 1 0.0001
500 LUNG INFECTION 1 0.0001
501 DRUG INEFFECTIVE 84 0.0001
502 ARRHYTHMIA 3 0.0001
503 HEAD INJURY 2 0.0001
504 PNEUMOTHORAX 1 0.0001
505 COMA 3 0.0001
506 ULCER 1 0.0001
507 CYSTITIS 2 0.0001
508 ABSCESS 1 0.0001
509 MUSCLE TIGHTNESS 1 0.0001
510 MUSCULAR WEAKNESS 7 0.0001
511 VISUAL ACUITY REDUCED 2 0.0001
512 COAGULOPATHY 1 0.0001
513 MUSCLE SPASMS 11 0.0001
514 ABDOMINAL DISCOMFORT 10 0.0001
515 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
516 HAEMATURIA 2 0.0001
517 MUSCULOSKELETAL STIFFNESS 5 0.0001
518 NEUROTOXICITY 1 0.0001
519 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
520 SKIN BURNING SENSATION 4 0.0001
521 LEUKOCYTOSIS 1 0.0001
522 HYPERGLYCAEMIA 2 0.0001
523 PHOTOPHOBIA 1 0.0001
524 BLOOD URINE PRESENT 1 0.0001
525 PROTEINURIA 1 0.0001
526 EAR PAIN 1 0.0001
527 DYSPHONIA 3 0.0001
528 CHOKING 1 0.0001
529 NASAL CONGESTION 3 0.0001
530 KIDNEY INFECTION 1 0.0001
531 BLOOD PRESSURE ABNORMAL 1 0.0001
532 DEVICE BREAKAGE 2 0.0000
533 BODY TEMPERATURE INCREASED 1 0.0000
534 VISUAL IMPAIRMENT 6 0.0000
535 PULMONARY HYPERTENSION 1 0.0000
536 OFF LABEL USE 42 0.0000
537 CEREBROVASCULAR ACCIDENT 8 0.0000
538 HYPERTENSION 10 0.0000
539 OSTEOARTHRITIS 2 0.0000
540 LIVER FUNCTION TEST INCREASED 1 0.0000
541 RECTAL HAEMORRHAGE 2 0.0000
542 HYPOACUSIS 2 0.0000
543 THROMBOCYTOPENIA 5 0.0000
544 SOMNOLENCE 9 0.0000
545 HYPOKALAEMIA 2 0.0000
546 SWELLING 4 0.0000
547 HYPOGLYCAEMIA 2 0.0000
548 LIVER INJURY 1 0.0000
549 ASTHENIA 15 0.0000
550 DIPLOPIA 1 0.0000
551 DEAFNESS 1 0.0000
552 MUSCULOSKELETAL PAIN 2 0.0000
553 PYREXIA 13 0.0000
554 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
555 JAUNDICE 1 0.0000
556 OEDEMA 2 0.0000
557 MOOD ALTERED 1 0.0000
558 PROCEDURAL PAIN 1 0.0000
559 WOUND 1 0.0000
560 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
561 FLATULENCE 2 0.0000
562 ANGINA PECTORIS 1 0.0000
563 EYE IRRITATION 2 0.0000
564 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
565 CATARACT 2 0.0000
566 RESPIRATORY DISORDER 1 0.0000
567 ADVERSE DRUG REACTION 3 0.0000
568 BLOOD POTASSIUM DECREASED 1 0.0000
569 LACRIMATION INCREASED 1 0.0000
570 FALL 11 0.0000
571 CORONARY ARTERY DISEASE 1 0.0000
572 STOMATITIS 2 0.0000
573 DRUG ADMINISTRATION ERROR 1 0.0000
574 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
575 LIMB DISCOMFORT 1 0.0000
576 DYSPHAGIA 3 0.0000
577 MOVEMENT DISORDER 1 0.0000
578 HIP FRACTURE 1 0.0000
579 PAIN 19 0.0000
580 LACTIC ACIDOSIS 1 0.0000
581 DEEP VEIN THROMBOSIS 2 0.0000
582 BLOOD CREATININE INCREASED 2 0.0000
583 PAIN IN EXTREMITY 9 0.0000
584 CHOLELITHIASIS 1 0.0000
585 IMPAIRED HEALING 1 0.0000
586 STAPHYLOCOCCAL INFECTION 1 0.0000
587 RENAL FAILURE 4 0.0000
588 EXPIRED PRODUCT ADMINISTERED 1 0.0000
589 SKIN DISORDER 1 0.0000
590 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
591 URINARY TRACT INFECTION 5 0.0000
592 HAEMOGLOBIN DECREASED 3 0.0000
593 INJECTION SITE REACTION 2 0.0000
594 CEREBRAL HAEMORRHAGE 1 0.0000
595 DRUG EFFECT INCOMPLETE 1 0.0000
596 CRYING 1 0.0000
597 C-REACTIVE PROTEIN INCREASED 1 0.0000
598 ACCIDENTAL OVERDOSE 1 0.0000
599 EYE SWELLING 1 0.0000
600 ASTHMA 3 0.0000
601 INTESTINAL OBSTRUCTION 1 0.0000
602 ANAEMIA 5 0.0000
603 CARDIAC FAILURE 2 0.0000
604 THROMBOSIS 2 0.0000
605 DRY MOUTH 2 0.0000
606 OEDEMA PERIPHERAL 3 0.0000
607 BLINDNESS 1 0.0000
608 OSTEOPOROSIS 1 0.0000
609 INTENTIONAL PRODUCT MISUSE 2 0.0000
610 DEHYDRATION 3 0.0000
611 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
612 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
613 RENAL DISORDER 1 0.0000
614 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
615 CARDIAC DISORDER 2 0.0000
616 BLOOD GLUCOSE INCREASED 4 0.0000
617 MIGRAINE 2 0.0000
618 MULTIPLE SCLEROSIS 1 0.0000
619 GAIT DISTURBANCE 4 0.0000
620 BLOOD GLUCOSE DECREASED 1 0.0000
621 PERIPHERAL SWELLING 3 0.0000
622 INFLAMMATION 1 0.0000
623 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
624 DIARRHOEA 12 0.0000
625 EYE PAIN 1 0.0000
626 MYOCARDIAL INFARCTION 3 0.0000
627 EXPOSURE DURING PREGNANCY 1 0.0000
628 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
629 INFECTION 2 0.0000
630 EPISTAXIS 1 0.0000
631 HALLUCINATION 1 0.0000
632 UNEVALUABLE EVENT 1 0.0000
633 CHRONIC KIDNEY DISEASE 1 0.0000
634 CONDITION AGGRAVATED 4 0.0000
635 DECREASED APPETITE 3 0.0000
636 FATIGUE 10 0.0000
637 INJECTION SITE HAEMORRHAGE 1 0.0000
638 CARDIAC FAILURE CONGESTIVE 1 0.0000
639 DRUG ABUSE 1 0.0000
640 MYALGIA 2 0.0000
641 BALANCE DISORDER 1 0.0000
642 GASTROINTESTINAL DISORDER 1 0.0000
643 SUICIDAL IDEATION 1 0.0000
644 OROPHARYNGEAL PAIN 1 0.0000
645 WEIGHT DECREASED 3 0.0000
646 DRUG INTOLERANCE 1 0.0000
647 PRODUCT DOSE OMISSION ISSUE 3 0.0000
648 DYSPEPSIA 1 0.0000
649 INJECTION SITE PAIN 3 0.0000
650 ILLNESS 1 0.0000
651 ABDOMINAL DISTENSION 1 0.0000
652 HAEMORRHAGE 1 0.0000
653 PLATELET COUNT DECREASED 1 0.0000
654 OVERDOSE 2 0.0000
655 CONSTIPATION 2 0.0000
656 SEPSIS 1 0.0000
657 INCORRECT DOSE ADMINISTERED 2 0.0000
658 DISEASE PROGRESSION 1 0.0000
659 JOINT SWELLING 1 0.0000
660 PSORIASIS 1 0.0000
661 INSOMNIA 2 0.0000
662 MEMORY IMPAIRMENT 1 0.0000
663 ARTHRALGIA 3 0.0000
664 DRUG DEPENDENCE 1 0.0000
665 PNEUMONIA 2 0.0000
666 TOXICITY TO VARIOUS AGENTS 1 0.0000
667 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
668 PRODUCT USE ISSUE 1 0.0000
669 DEATH 4 0.0000
670 WEIGHT INCREASED 1 0.0000